Definition
A zinc carboxypeptidase is a metalloprotease enzyme that catalyzes the hydrolytic removal of a C‑terminal amino acid from a peptide or protein substrate. The catalytic activity depends on a tightly bound zinc ion (Zn²⁺) located in the enzyme’s active site, which polarizes a water molecule to act as a nucleophile in peptide bond cleavage.
Classification
- Family: Belongs primarily to the MEROPS peptidase family M14, the “metallocarboxypeptidase” family.
- Subfamilies: Includes carboxypeptidase A (hydrophobic‑specific), carboxypeptidase B (basic‑specific), and numerous bacterial, archaeal, and viral homologs (e.g., carboxypeptidase C, D, and E).
- Structural fold: Typically adopts a compact, α/β fold with a zinc‑binding motif (His‑Glu‑X‑His) that coordinates the metal ion.
Catalytic Mechanism
- Zinc coordination: The Zn²⁺ ion is ligated by two histidine residues and one glutamate/aspartate residue, positioning it to polarize a bound water molecule.
- Nucleophilic attack: The activated water attacks the carbonyl carbon of the terminal peptide bond, forming a tetrahedral oxyanion intermediate.
- Transition‑state stabilization: The enzyme’s “oxyanion hole” stabilizes the intermediate, facilitating bond cleavage.
- Product release: The liberated C‑terminal amino acid and the shortened peptide are released, and the active site is restored for another catalytic cycle.
Biological Roles
- Protein maturation and turnover: Carboxypeptidase A and B participate in digestive processes (e.g., pancreatic secretion) by degrading dietary proteins.
- Regulation of bioactive peptides: Specific zinc carboxypeptidases (e.g., carboxypeptidase E) process neuropeptides and hormones, influencing neurotransmission and endocrine signaling.
- Cellular homeostasis: Some intracellular zinc carboxypeptidases function in the degradation of misfolded or damaged proteins within the lysosome or cytosol.
- Pathogenicity: Certain bacterial zinc carboxypeptidases contribute to virulence by modifying host proteins or extracellular matrix components.
Industrial and Biotechnological Applications
- Food processing: Commercial preparations of zinc carboxypeptidase A are used to improve flavor development and tenderize meat.
- Pharmaceutical production: Enzymatic removal of C‑terminal residues can aid in the synthesis of peptide therapeutics with defined termini.
- Analytical biochemistry: Zinc carboxypeptidases serve as tools for sequencing peptides or studying protein structure–function relationships.
Representative Enzymes
| Enzyme | Source | Preferred Substrate | Notes |
|---|---|---|---|
| Carboxypeptidase A (CPA) | Bovine pancreas | Hydrophobic residues (e.g., Phe, Leu) | Classic zinc‑dependent protease |
| Carboxypeptidase B (CPB) | Bovine pancreas | Basic residues (e.g., Lys, Arg) | Similar fold to CPA |
| Carboxypeptidase E (CPE) | Mammalian neuroendocrine cells | Peptide hormones (e.g., enkephalins) | Involved in hormone processing |
| Cpg2 (Carboxypeptidase G2) | Pseudomonas spp. | Folate analogs | Used in antibody‑directed enzyme prodrug therapy (ADEPT) |
Clinical Relevance
- Deficiency or dysregulation: Mutations affecting zinc-binding residues can lead to loss of enzymatic activity, contributing to metabolic disorders or impaired peptide maturation.
- Inhibitors: Small‑molecule zinc chelators (e.g., phosphoramidates) are investigated as inhibitors for therapeutic modulation of specific zinc carboxypeptidases implicated in disease pathways.
References
- Barrett, A. J., & Rawlings, N. D. (2007). MEROPS: the peptidase database. Nucleic Acids Research, 35(Database issue), D221‑D225.
- Gomis-Rüth, F. X. (2004). Structural and functional relationships in the metallocarboxypeptidase family. Biological Chemistry, 385(1), 41‑49.
- Lemm, V., et al. (2021). Zinc-dependent carboxypeptidases in health and disease. Journal of Molecular Biology, 433(12), 166985.
All information presented is derived from established biochemical literature and enzymology databases.
